Liver Function Test (LFT) at Ayzal Lab

Liver Function Test (LFT) at Ayzal Lab

A Liver Function Test (LFT), also known as a hepatic panel, is a comprehensive group of blood tests designed to evaluate the clinical state of your liver. This essential laboratory investigation measures the levels of specific proteins, liver enzymes, and bilirubin in your blood sample. The liver is a vital organ located in the upper right quadrant of the abdomen, responsible for critical metabolic processes, detoxification of harmful substances, protein synthesis, and the production of bile to aid digestion. By analyzing these biochemical markers, healthcare providers can gain valuable insights into how effectively your liver is performing its physiological functions.

At Ayzal Lab, located in Lahore, Pakistan, we utilize advanced automated clinical chemistry analyzers to perform Liver Function Tests with high precision and accuracy. The test works by measuring the concentration of cellular enzymes that leak into the bloodstream when liver cells (hepatocytes) are damaged or inflamed. It also measures the liver’s synthetic capacity by evaluating proteins like albumin and total protein, as well as its excretory function through bilirubin levels. This diagnostic tool is highly valuable for screening, diagnosing, and monitoring various hepatic conditions, ensuring that patients receive timely and appropriate medical interventions.

The anatomical and physiological structures evaluated through an LFT primarily include the hepatocytes, the biliary tract (bile ducts), and the overall metabolic pathways of the liver. Clinically, this test is of paramount importance because liver disease often progresses silently without obvious symptoms in its early stages. Regular screening through LFTs allows for the early detection of liver injury caused by viral infections, alcohol consumption, hepatotoxic medications, or metabolic disorders. The benefits of undergoing this test at Ayzal Lab include access to reliable, high-quality diagnostic data, rapid turnaround times, and professional reporting that assists your consulting physician in formulating an accurate treatment plan.

Common clinical indications for ordering a Liver Function Test include a history of alcohol abuse, exposure to hepatitis viruses, a family history of liver disease, obesity, diabetes, and the use of medications known to cause liver toxicity. Additionally, physicians frequently request this panel for patients presenting with symptoms such as jaundice (yellowing of the skin and eyes), abdominal pain, unexplained fatigue, dark urine, or pale stools. By providing a clear biochemical profile of your liver, the LFT serves as a cornerstone of modern diagnostic hepatology.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy of your Liver Function Test results at Ayzal Lab, proper patient preparation is essential. Please adhere to the following guidelines prior to your blood draw:

• Fasting Requirements: You are generally required to fast for 8 to 12 hours before the test. This means you should not eat or drink anything except plain water. Fasting is particularly important because eating can temporarily alter the levels of certain liver enzymes and bilirubin.
• Medication Disclosure: Inform your prescribing doctor and the laboratory staff at Ayzal Lab about all medications, dietary supplements, herbal remedies, and over-the-counter drugs you are currently taking. Certain medications, such as pain relievers, antibiotics, and lipid-lowering drugs, can affect liver enzyme levels.
• Avoid Alcohol: Do not consume alcohol for at least 24 to 48 hours before the test, as alcohol can cause acute, temporary spikes in liver enzymes, leading to misleading results.
• Hydration: Drink plenty of plain water during your fasting period. Staying well-hydrated makes your veins more accessible, facilitating a smoother blood collection process.
• Rest: Avoid strenuous physical exercise immediately before the test, as extreme physical exertion can influence muscle-related enzymes that sometimes overlap with liver panels.

During the Procedure

The Liver Function Test is a standard venipuncture procedure performed by our experienced phlebotomists at Ayzal Lab. When you arrive, you will be comfortably seated in a blood collection chair. The phlebotomist will ask you to extend your arm and will locate a suitable vein, typically in the crease of your elbow (antecubital fossa). The selected area will be thoroughly cleansed with an antiseptic swab to prevent any localized infection.

A sterile elastic band (tourniquet) will be tied around your upper arm to increase blood pressure in the veins, making them more visible and easier to access. The phlebotomist will then gently insert a sterile, single-use needle into the vein. You may feel a brief, minor pinch or prick as the needle enters the skin. Blood will flow into a vacuum collection tube designed specifically for clinical chemistry panels.

Once the required volume of blood is collected, the tourniquet is released, and the needle is carefully withdrawn. A sterile cotton ball or gauze pad will be pressed firmly against the puncture site to stop any minor bleeding, and a small adhesive bandage will be applied. The entire sample collection process takes less than five minutes. The collected blood sample is then barcoded, registered in our laboratory information system, and sent directly to our clinical chemistry department for automated analysis under strict quality control protocols.

When is a Liver Function Test (LFT) Performed?

Evaluation of Jaundice

A Liver Function Test is urgently performed when a patient exhibits signs of jaundice, characterized by a distinct yellowing of the skin, mucous membranes, and the sclera (whites of the eyes). Jaundice occurs due to an accumulation of bilirubin, a yellowish pigment formed during the normal breakdown of red blood cells. When the liver or biliary system is compromised, it cannot process or excrete bilirubin efficiently. The LFT measures both conjugated (direct) and unconjugated (indirect) bilirubin levels, helping clinicians determine whether the cause is pre-hepatic (excessive red blood cell breakdown), hepatic (liver cell damage), or post-hepatic (biliary obstruction).

Monitoring Hepatotoxic Medications

Many commonly prescribed medications, including statins, nonsteroidal anti-inflammatory drugs (NSAIDs), certain antibiotics, anti-tuberculosis drugs, and anticonvulsants, are metabolized by the liver and can potentially cause drug-induced liver injury (DILI). Physicians routinely order LFTs before initiating these medications to establish a baseline and at regular intervals during treatment. If the test reveals a significant rise in liver enzymes such as Alanine Aminotransferase (ALT) or Aspartate Aminotransferase (AST), the physician may adjust the dosage or switch to an alternative medication to prevent permanent liver damage.

Assessment of Chronic Alcohol Consumption

Chronic alcohol consumption is a leading cause of liver disease, ranging from fatty liver (steatosis) to alcoholic hepatitis and cirrhosis. Physicians request an LFT for patients with a history of heavy alcohol use to assess the degree of liver injury. In alcoholic liver disease, the ratio of AST to ALT is often characteristically elevated (typically greater than 2:1). Additionally, Gamma-Glutamyl Transferase (GGT) is highly sensitive to alcohol intake and serves as a key marker for monitoring alcohol-induced hepatic stress and patient compliance during recovery programs.

Screening for Viral Hepatitis

Viral hepatitis (including Hepatitis A, B, C, D, and E) causes acute or chronic inflammation of the liver parenchyma. Patients presenting with flu-like symptoms, dark-colored urine, pale stools, and abdominal discomfort are routinely screened using an LFT. The test detects marked elevations in aminotransferases (ALT and AST), which often rise significantly before the onset of jaundice. Identifying these elevated markers prompts further specific serological testing for viral antigens and antibodies, enabling early diagnosis and antiviral therapy.

Management of Non-Alcoholic Fatty Liver Disease (NAFLD)

With the rising prevalence of metabolic syndrome, obesity, and type 2 diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD) and its progressive form, Non-Alcoholic Steatohepatitis (NASH), have become highly common. Physicians perform LFTs in patients with metabolic risk factors to screen for silent liver inflammation. Elevated ALT levels in the absence of other causes often point toward NAFLD. Regular LFT monitoring helps healthcare providers evaluate the effectiveness of lifestyle modifications, dietary changes, and medical therapies aimed at reducing hepatic fat accumulation.

What Does a Liver Function Test (LFT) Detect?

A Liver Function Test at Ayzal Lab evaluates a comprehensive panel of biomarkers to detect a wide range of physiological and pathological conditions. Specifically, the test is designed to detect and quantify:

• Elevated Alanine Aminotransferase (ALT) indicating acute hepatocellular injury.
• Elevated Aspartate Aminotransferase (AST) suggesting liver cell damage or muscle injury.
• An AST/ALT ratio greater than 2, commonly associated with alcoholic liver disease.
• Increased Alkaline Phosphatase (ALP) indicating cholestasis or biliary tract obstruction.
• Elevated Gamma-Glutamyl Transferase (GGT) pointing to biliary tract disease or alcohol consumption.
• Hyperbilirubinemia (elevated total bilirubin) causing clinical jaundice.
• Elevated direct (conjugated) bilirubin suggesting post-hepatic biliary obstruction or hepatocellular dysfunction.
• Elevated indirect (unconjugated) bilirubin indicating hemolysis or impaired hepatic uptake.
• Hypoalbuminemia (low albumin levels) indicating chronic liver disease or impaired synthetic capacity.
• Decreased total protein levels reflecting severe malnutrition or advanced liver cirrhosis.
• Elevated total protein levels associated with chronic inflammation or plasma cell disorders.
• Acute liver injury resulting from acetaminophen (paracetamol) toxicity.
• Drug-induced liver injury (DILI) from various therapeutic agents.
• Early-stage non-alcoholic fatty liver disease (NAFLD).
• Progression of non-alcoholic steatohepatitis (NASH).
• Chronic viral hepatitis B and C infections.
• Autoimmune hepatitis, characterized by immune-mediated liver inflammation.
• Primary Biliary Cholangitis (PBC) through elevated ALP and GGT.
• Primary Sclerosing Cholangitis (PSC) affecting the bile ducts.
• Hepatic congestion secondary to congestive heart failure.
• Cirrhosis, representing advanced, irreversible scarring of liver tissue.
• Hemochromatosis, an iron overload disorder affecting hepatic function.
• Wilson’s disease, a rare genetic disorder causing copper accumulation in the liver.
• Alpha-1 antitrypsin deficiency leading to liver and lung disease.
• The presence of space-occupying lesions or hepatic tumors (in conjunction with tumor markers).
• Impaired synthetic function prior to major surgical procedures.
• Efficacy and safety of ongoing hepatotoxic medical treatments.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that receiving your diagnostic results promptly is crucial for your peace of mind and timely medical care. Our laboratory operates with highly efficient workflows and state-of-the-art automated systems to ensure rapid processing of blood samples. Typically, the routine Liver Function Test (LFT) reports are completed and verified by our consultant pathologists within a few hours of sample collection.

Once your report is finalized, you will receive an automated SMS notification on your registered mobile number. Ayzal Lab offers multiple convenient ways to access your diagnostic reports. Patients can download their reports directly from our secure online portal or official website using their unique patient ID and password. Additionally, physical copies of the reports can be collected from our main reception desk or any of our designated collection centers in Lahore. We ensure that all patient data is handled with the highest level of confidentiality and security.

Liver Function Test (LFT) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Alanine Aminotransferase (ALT)	Low levels (typically 7-56 U/L)	Markedly elevated in acute hepatitis; moderately elevated in fatty liver and cirrhosis.
Aspartate Aminotransferase (AST)	Low levels (typically 10-40 U/L)	Elevated in liver injury, myocardial infarction, muscle trauma, and alcoholic hepatitis.
Alkaline Phosphatase (ALP)	Moderate levels (typically 44-147 U/L)	Significantly elevated in biliary obstruction, gallstones, and bone disorders.
Gamma-Glutamyl Transferase (GGT)	Low to moderate levels (typically 9-48 U/L)	Elevated in bile duct obstruction, alcohol abuse, and hepatotoxic drug use.
Total Bilirubin	Low levels (typically 0.1-1.2 mg/dL)	Elevated in jaundice, hemolytic anemia, biliary obstruction, and hepatitis.
Direct (Conjugated) Bilirubin	Very low levels (typically less than 0.3 mg/dL)	Elevated in gallstones, bile duct tumors, and hepatocellular damage.
Albumin	High levels (typically 3.5-5.0 g/dL)	Decreased in chronic liver disease, cirrhosis, malnutrition, and kidney disease.
Total Protein	Normal range (typically 6.0-8.3 g/dL)	Decreased in liver failure; elevated in chronic infections and multiple myeloma.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Liver Function Test (LFT)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, clinical biochemists, and skilled phlebotomists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the sample collection and reporting process.
• Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control measures to ensure highly accurate and reproducible test results.
• Professional Reporting: Our diagnostic reports are detailed, structured, and easy for both patients and consulting physicians to interpret.
• Modern Diagnostic Approach: We utilize state-of-the-art automated analyzers and advanced laboratory technologies for precise biochemical analysis.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free environment for all patients.
• Convenient Location: Easily accessible facilities across Lahore make it simple for patients to visit for routine and specialized testing.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable diagnostic insights that form a solid foundation for effective clinical decisions.